Transvaginal Mesh Lawyers
Transvaginal mesh (TVM) is a medical device used to treat women suffering from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). The product is surgically implanted to help hold a woman’s internal organs in place and help prevent them from “sagging” inside her body cavity. Despite its widespread use, TVM has come under increased scrutiny after being linked to severe health complications that sometimes require further revision surgeries.
At Ferrer, Poirot & Wansbrough, we know the health complications caused by defective Transvaginal mesh implants can be life altering, and treatment of TVM injuries can be traumatic and expensive. Many patients who were injured by TVM have pursued legal action to recover damages for medical bills, lost wages, and pain and suffering.
If you’re considering a transvaginal mesh lawsuit, contact us today. We have more than 35 years of experience helping injured victims across the United States, and whether it means settling out of court or filing a lawsuit, we’re here to protect your rights to compensation.
Transvaginal Mesh Side Effects
There are multiple manufacturers of surgical mesh used in transvaginal mesh procedures, and the risks of painful complications—such as pain during intercourse and organ perforation—appear to be present regardless of the brand used by your surgeon.
FDA Transvaginal Mesh Warnings
In April 2019, the FDA ordered manufacturers of all TVM devices to stop selling and distributing their products in the U.S. effective immediately. This order came after the FDA determined that two TVM manufacturers had not demonstrated “a reasonable assurance of safety and effectiveness” for their products—a requirement for the devices since their reclassification to class III (high risk) in 2016.
Since 2005, the U.S. Food and Drug Administration has received more than 3,800 reports of adverse health events related to surgical mesh used to repair POP or SUI. These reports and other factors led the FDA to release a safety alert in July 2011 warning doctors and patients about the risks of TVM.
In Jan. 2016, the FDA issued two orders to strengthen the requirements for TVM used in the repair of POP. The first order reclassifies surgical mesh from a class II device, which indicates moderate risk, to class III, which generally includes high-risk devices. The FDA also ordered TVM manufacturers to submit documentation that demonstrates the safety and effectiveness of surgical mesh for transvaginal repair of POP.
Experienced Legal Representation
If you or someone you love was injured by pelvic mesh, Ferrer, Poirot & Wansbrough is here for you. Our transvaginal mesh lawyers want to help you get the compensation you deserve for your injury-related expenses and pain and suffering. Contact our legal team 24/7—just dial (800) 210-8503 or complete a free initial consultation form to get help with your TVM lawsuit, today.
This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration.
Cases may be referred to another attorney or law firm.